Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Charles

Showing results (471-480 of 519) with videos related to

Pageof 52
Sort By:
Nature Medicine|May 24, 2011
Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancerGeorgios Giamas, Aleksandra Filipović, Jimmy Jacob, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2015
SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast CancerWilbert Zwart, Koen D Flach, Bharath Rudraraju, et al.
Breast Cancer Research and Treatment|September 25, 2014
Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cellsAleksandra Filipović, Ylenia Lombardo, Monica Faronato, et al.
Nucleic Acids Research|September 20, 2013
Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cellsChun-Fui Lai, Koen D Flach, Xanthippi Alexi, et al.
Nature Communications|November 28, 2015
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
ACS Nano|January 28, 2016
Spearhead Nanometric Field-Effect Transistor Sensors for Single-Cell AnalysisYanjun Zhang, Jan Clausmeyer, Babak Babakinejad, et al.
The Journal of Liquid Biopsy|June 22, 2026
Development of a LiDia-SEQ™ platform compatible breast cancer panel and testing with metastatic breast cancer patient samples: A rapid, sample-to-result, fully integrated next-generation sequencing (NGS)-based platform, LiDia-SEQ, for use at the point-of-needMohammadali Yavari Ramsheh, Raquel L Fraccari, Rossitza Christova, et al.
Breast Cancer Research and Treatment|July 8, 2010
The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cellsPaul T R Thiruchelvam, Chun-Fui Lai, Hui Hua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancerR Charles Coombes, Judith M Bliss, Marc Espie, et al.
Cureus|August 28, 2025
Colorectal Cancer Risk and Protective Factors Among People of African Descent: A Systematic Review and Meta-AnalysisCollins C Okeke, Angela Ojo, Onyinye E Ebiliekwe, et al.
Pageof 52

Showing results (471-480 of 519) with videos related to

Sort By:
Pageof 52
Nature Medicine|May 24, 2011
Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancerGeorgios Giamas, Aleksandra Filipović, Jimmy Jacob, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2015
SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast CancerWilbert Zwart, Koen D Flach, Bharath Rudraraju, et al.
Breast Cancer Research and Treatment|September 25, 2014
Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cellsAleksandra Filipović, Ylenia Lombardo, Monica Faronato, et al.
Nucleic Acids Research|September 20, 2013
Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cellsChun-Fui Lai, Koen D Flach, Xanthippi Alexi, et al.
Nature Communications|November 28, 2015
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
ACS Nano|January 28, 2016
Spearhead Nanometric Field-Effect Transistor Sensors for Single-Cell AnalysisYanjun Zhang, Jan Clausmeyer, Babak Babakinejad, et al.
The Journal of Liquid Biopsy|June 22, 2026
Development of a LiDia-SEQ™ platform compatible breast cancer panel and testing with metastatic breast cancer patient samples: A rapid, sample-to-result, fully integrated next-generation sequencing (NGS)-based platform, LiDia-SEQ, for use at the point-of-needMohammadali Yavari Ramsheh, Raquel L Fraccari, Rossitza Christova, et al.
Breast Cancer Research and Treatment|July 8, 2010
The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cellsPaul T R Thiruchelvam, Chun-Fui Lai, Hui Hua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancerR Charles Coombes, Judith M Bliss, Marc Espie, et al.
Cureus|August 28, 2025
Colorectal Cancer Risk and Protective Factors Among People of African Descent: A Systematic Review and Meta-AnalysisCollins C Okeke, Angela Ojo, Onyinye E Ebiliekwe, et al.
Pageof 52